The senior consultant for the department of neurology at the National Neuroscience Institute shares what he looks forward to at this year's ECTRIMS conference. [WATCH TIME: 2 minutes]
WATCH TIME: 2 minutes
“I think I just want to know, the newest things happening in MS. The newest treatments and I mean, there's quite a few of them on the horizon so I'd like to hear a bit more about that.”
The 38th 2022 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, held in Amsterdam, Netherlands, from October 26-28, will feature 9000 participants, 200 speakers, and 50 international exhibitions. Among the many attendees, Tianrong Yeo, MBBS, MRCP, MMED, FAMS, MCI, PhD, is presenting a poster on neutralizing antibodies in patients with multiple sclerosis, neuromyelitis optica spectrum disorder, and other neuroimmunological disorders, who’ve received SARS-CoV-2 mRNA vaccinations. Yeo, a senior consultant in the department of neurology at the National Neuroscience Institute in Singapore, expressed that he has a clinical interest in neurologic conditions with a research interest more in the environmental factors of MS and neuro inflammation.
In a recent interview with NeurologyLive®, Yeo discussed what he looks forward to at the upcoming meeting. He looks forward to hearing about the newest happenings in MS, including the latest treatments, and his colleague’s presentation as well.